Genetic Overview
- Year Founded
-
2000

- Status
-
Private
- Employees
-
201

- Latest Deal Type
-
Buyout/LBO
- (Rumor/Speculation)
- Financing Rounds
-
2
Genetic General Information
Description
Operator of a pharma contract development and manufacturing firm(CDMO) focused on developing and supplying products into the respiratory, ophthalmic and oncology therapeutic areas. The company specializes in the research, development, manufacturing, licensing and promotion of pharmaceutical specialties and medical devices with primary expertise in the development of respiratory and ophthalmology products that are delivered via unit-dose blow-fill-deal technology, pressurized metered-dose inhalers, nasal sprays as well as an eye drop and collyrium technologies.
Contact Information
Website
www.geneticspa.comCorporate Office
- Contrada Canfora
- 84084 Fisciano(Salerno)
- Italy
Corporate Office
- Contrada Canfora
- 84084 Fisciano(Salerno)
- Italy
Genetic Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Genetic Comparisons
Industry
Financing
Details
Genetic Competitors (2)
One of Genetic’s 2 competitors is BSP Pharmaceuticals, a Corporation company based in Latina Scalo, Italy.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
BSP Pharmaceuticals | Corporation | Latina Scalo, Italy | ||||
medac Pharma UK | Corporation | Stirling, United Kingdom |
Genetic Patents
Genetic Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
EP-4373833-A1 | Process for the preparation of budesonide 21-phosphate | Pending | 22-Jul-2021 | ||
US-20240343757-A1 | Process for the preparation of budesonide 21-phosphate | Pending | 22-Jul-2021 | ||
EP-4373495-A2 | Budesonide 21-phosphate sodium salt for use as anti-inflammatory or anti-asthmatic agent | Pending | 21-Jul-2021 | ||
US-20250090551-A1 | Budesonide 21-phosphate sodium salt for use as anti-inflammatory or antiasthmatic agent | Pending | 21-Jul-2021 | ||
US-20230115869-A1 | Budesonide 21-phosphate salts and pharmaceutical compositions containing the same | Pending | 27-Mar-2020 | C07J71/0031 |
Genetic Signals
Genetic Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
Genetic Affiliates
Subsidiaries (2)
Name | Industry | Location | Year Founded |
---|---|---|---|
Genelife | Fisciano, Italy | 2018 | |
Genetic Farma | Castel San Giorgio, Italy | 1996 |
Genetic FAQs
-
When was Genetic founded?
Genetic was founded in 2000.
-
Where is Genetic headquartered?
Genetic is headquartered in Fisciano, Italy.
-
What is the size of Genetic?
Genetic has 201 total employees.
-
What industry is Genetic in?
Genetic’s primary industry is BPO/Outsource Services.
-
Is Genetic a private or public company?
Genetic is a Private company.
-
What is the current valuation of Genetic?
The current valuation of Genetic is
. -
What is Genetic’s current revenue?
The current revenue for Genetic is
. -
Who are Genetic’s investors?
CVC Capital Partners has invested in Genetic.
-
Who are Genetic’s competitors?
BSP Pharmaceuticals and medac Pharma UK are competitors of Genetic.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »